These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 6455800)
1. Specific immunosuppression and graft survival. Brent L; Hutchinson IV Transplant Proc; 1981 Mar; 13(1 Pt 1):541-6. PubMed ID: 6455800 [No Abstract] [Full Text] [Related]
2. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss. Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116 [TBL] [Abstract][Full Text] [Related]
4. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches. Duguid IG; Koulmanda M; Mandel TE Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499 [No Abstract] [Full Text] [Related]
5. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities. Ohzato H; Monaco AP Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307 [No Abstract] [Full Text] [Related]
6. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens. Halliday GM; Odling KA; Muller HK Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936 [TBL] [Abstract][Full Text] [Related]
7. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to complement C3 prolong survival of discordant xenografts: guinea pig heart to rat transplantation. Kemp E; Dieperink H; Leth P; Jensenius JC; Nielsen B; Lillevang ST; Salomon S; Steinbrüchel D; Larsen S; Koch C Transplant Proc; 1994 Apr; 26(2):1011-5. PubMed ID: 8171451 [No Abstract] [Full Text] [Related]
9. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier. Koch U; Choksi S; Marcucci L; Korngold R J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252 [TBL] [Abstract][Full Text] [Related]
10. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor. Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620 [TBL] [Abstract][Full Text] [Related]
12. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides. Zeng Y; Torres M; Wang Y; Montag A; Thistlethwaite JR Transplant Proc; 1995 Feb; 27(1):176-7. PubMed ID: 7878961 [No Abstract] [Full Text] [Related]
13. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related]
14. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783 [TBL] [Abstract][Full Text] [Related]
15. The influence of xenotransplant immunogenicity and immunosuppression on host MHC expression in the rat CNS. Czech KA; Ryan JW; Sagen J; Pappas GD Exp Neurol; 1997 Sep; 147(1):66-83. PubMed ID: 9294404 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell chimerism: relationships between degree of chimerism, T cell clonal deletion, and graft survival. Taniguchi H; Jinzenji Y; Fukao K; Nakauchi H Transplant Proc; 1994 Aug; 26(4):1966-8. PubMed ID: 8066636 [No Abstract] [Full Text] [Related]
17. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats. Hamashima T; Stepkowski SM; Smith S; Kahan BD Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960 [No Abstract] [Full Text] [Related]
18. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection. Yen CY; Lin CY J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649 [TBL] [Abstract][Full Text] [Related]